Envoy Medical, Inc. (COCH) Earnings History
Annual and quarterly earnings data from 2021 to 2025
Loading earnings history...
COCH EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
COCH Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | -262.7% | -9240.7% | -9857.3% |
| 2024 | -229.8% | -8558.2% | -9242.2% |
| 2023 | -149.7% | -5809.8% | -9469.0% |
| 2022 | -110.1% | -3673.4% | -6718.6% |
| 2021 | -148.1% | -2216.5% | -2798.4% |
Download Data
Export COCH earnings history in CSV or JSON format
Free sign-in required to download data
Envoy Medical, Inc. (COCH) Earnings Overview
As of May 8, 2026, Envoy Medical, Inc. (COCH) reported trailing twelve-month net income of -$24M, reflecting +17.4% year-over-year growth. The company earned $-1.21 per diluted share over the past four quarters, with a net profit margin of -9857.3%.
Looking at the long-term picture, COCH's historical earnings data spans multiple years. The company achieved its highest annual net income of -$9M in fiscal 2021.
Envoy Medical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including LNTH ($279M net income, 15.2% margin), MDT ($4.61B net income, 13.9% margin), ABT ($13.98B net income, 31.9% margin), COCH has room to improve margins relative to the peer group. Compare COCH vs LNTH →
COCH Earnings vs Peers
Earnings metrics vs comparable public companies
COCH Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$24M | -14.2% | -$22M | $-1.23 | -9857.3% | -9240.7% |
| 2024 | -$21M | +30.5% | -$19M | $-1.49 | -9242.2% | -8558.2% |
| 2023 | -$30M | -87.9% | -$18M | $-2.54 | -9469.0% | -5809.8% |
| 2022 | -$16M | -83.6% | -$9M | $-1.57 | -6718.6% | -3673.4% |
| 2021 | -$9M | - | -$7M | $-1.05 | -2798.4% | -2216.5% |
See COCH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs COCH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare COCH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCOCH — Frequently Asked Questions
Quick answers to the most common questions about buying COCH stock.
Is COCH growing earnings?
COCH EPS is $-1.21, with earnings growth accelerating to +17.4%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-24M.
What are COCH's profit margins?
Envoy Medical, Inc. net margin is -9857.3%, with operating margin at -9240.7%. Below-average margins reflect competitive or cost pressures.
How consistent are COCH's earnings?
COCH earnings data spans 2021-2025. The accelerating earnings trend is +17.4% YoY. Historical data enables comparison across business cycles.